|
1
|
Misra S, Chaturvedi A, Misra NC and Sharma
ID: Carcinoma of the gallbladder. Lancet Oncol. 4:167–176. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Andia ME, Hsing AW, Andreotti G and
Ferreccio C: Geographic variation of gallbladder cancer mortality
and risk factors in Chile: A population-based ecologic study. Int J
Cancer. 123:1411–1416. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pilgrim CH, Groeschl RT, Christians KK and
Gamblin TC: Modern perspectives on factors predisposing to the
development of gallbladder cancer. HPB (Oxford). 15:839–844. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iyer P, Barreto SG, Sahoo B, Chandrani P,
Ramadwar MR, Shrikhande SV and Dutt A: Non-typhoidal Salmonella DNA
traces in gallbladder cancer. Infect Agent Cancer. 11:122016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jain K, Sreenivas V, Velpandian T, Kapil U
and Garg PK: Risk factors for gallbladder cancer: A case-control
study. Int J Cancer. 132:1660–1666. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hundal R and Shaffer EA: Gallbladder
cancer: Epidemiology and outcome. Clin Epidemiol. 6:99–109.
2014.PubMed/NCBI
|
|
7
|
Yang XW, Yang J, Li L, Man XB, Zhang BH,
Shen F and Wu MC: Analysis of the relationships between
clinicopathologic factors and survival in gallbladder cancer
following surgical resection with curative intent. PLoS One.
7:e515132012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sasatomi E, Tokunaga O and Miyazaki K:
Precancerous conditions of gallbladder carcinoma: Overview of
histopathologic characteristics and molecular genetic findings. J
Hepatobiliary Pancreat Surg. 7:556–567. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rashid A: Cellular and molecular biology
of biliary tract cancers. Surg Oncol Clin N Am. 11:995–1009. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mo YY: MicroRNA regulatory networks and
human disease. Cell Mol Life Sci. 69:3529–3531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Johnson CD, Esquela-Kerscher A, Stefani G,
Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J,
Shingara J, et al: The let-7 microRNA represses cell proliferation
pathways in human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Inui M, Martello G and Piccolo S: MicroRNA
control of signal transduction. Nat Rev Mol Cell Biol. 11:252–263.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okayama H, Schetter AJ and Harris CC:
MicroRNAs and inflammation in the pathogenesis and progression of
colon cancer. Dig Dis. 30 (Suppl 2):S9–S15. 2012. View Article : Google Scholar
|
|
16
|
Schetter AJ, Heegaard NH and Harris CC:
Inflammation and cancer: Interweaving microRNA, free radical,
cytokine and p53 pathways. Carcinogenesis. 31:37–49. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kono H, Nakamura M, Ohtsuka T, Nagayoshi
Y, Mori Y, Takahata S, Aishima S and Tanaka M: High expression of
microRNA-155 is associated with the aggressive malignant behavior
of gallbladder carcinoma. Oncol Rep. 30:17–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Letelier P, García P, Leal P, Álvarez H,
Ili C, López J, Castillo J, Brebi P and Roa JC: miR-1 and miR-145
act as tumor suppressor microRNAs in gallbladder cancer. Int J Clin
Exp Pathol. 7:1849–1867. 2014.PubMed/NCBI
|
|
19
|
Zhou H, Wang Y, Zha R, Ding J, Liang L, Hu
J, Shen H, Chen Z, Guo W, Zhao Y, et al: MicroRNA-26a acts as a
tumor suppressor inhibiting gallbladder cancer cell proliferation
by directly targeting HMGA2. Int J Oncol. 44:2050–2058. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou H, Guo W, Zhao Y, Wang Y, Zha R, Ding
J, Liang L, Yang G, Chen Z, Ma B and Yin B: MicroRNA-135a acts as a
putative tumor suppressor by directly targeting very low density
lipoprotein receptor in human gallbladder cancer. Cancer Sci.
105:956–965. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng HH, Zhang YD, Gong LS, Liu WD and
Zhang Y: Increased expression of microRNA-335 predicts a favorable
prognosis in primary gallbladder carcinoma. Onco Targets Ther.
6:1625–1630. 2013.PubMed/NCBI
|
|
22
|
Yoon SO, Kim EK, Lee M, Jung WY, Lee H,
Kang Y, Jang YJ, Hong SW, Choi SH and Yang WI: NOVA1 inhibition by
miR-146b-5p in the remnant tissue microenvironment defines occult
residual disease after gastric cancer removal. Oncotarget.
7:2475–2495. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deng X, Wu B, Xiao K, Kang J, Xie J, Zhang
X and Fan Y: MiR-146b-5p promotes metastasis and induces
epithelial-mesenchymal transition in thyroid cancer by targeting
ZNRF3. Cell Physiol Biochem. 35:71–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu E, Zhao J, Ma J, Wang C, Zhang C, Jiang
H, Cheng J, Gao R and Zhou X: miR-146b-5p promotes invasion and
metastasis contributing to chemoresistance in osteosarcoma by
targeting zinc and ring finger 3. Oncol Rep. 35:275–283. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu J, Xu J, Li H, Sun C, Yu L, Li Y, Shi
C, Zhou X, Bian X, Ping Y, et al: miR-146b-5p functions as a tumor
suppressor by targeting TRAF6 and predicts the prognosis of human
gliomas. Oncotarget. 6:29129–29142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cai J, Xu L, Cai Z, Wang J, Zhou B and Hu
H: MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by
targeting epidermal growth factor receptor. Mol Med Rep.
12:1549–1555. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Byrd-Leifer CA, Block EF, Takeda K, Akira
S and Ding A: The role of MyD88 and TLR4 in the LPS-mimetic
activity of Taxol. Eur J Immunol. 31:2448–2457. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang JM, Zhang GN, Shi Y, Zha X, Zhu Y,
Wang MM, Lin Q, Wang W, Lu HY, Ma SQ, et al: Atractylenolide-I
sensitizes human ovarian cancer cells to paclitaxel by blocking
activation of TLR4/MyD88-dependent pathway. Sci Rep. 4:38402014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kawasaki T and Kawai T: Toll-like receptor
signaling pathways. Front Immunol. 5:4612014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang AC, Ma YB, Wu FX, Ma ZF, Liu NF, Gao
R, Gao YS and Sheng XG: TLR4 induces tumor growth and inhibits
paclitaxel activity in MyD88-positive human ovarian carcinoma in
vitro. Oncol Lett. 7:871–877. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kawasaki K, Akashi S, Shimazu R, Yoshida
T, Miyake K and Nishijima M: Mouse toll-like receptor 4.MD-2
complex mediates lipopolysaccharide-mimetic signal transduction by
Taxol. J Biol Chem. 275:2251–2254. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rajput S, Volk-Draper LD and Ran S: TLR4
is a novel determinant of the response to paclitaxel in breast
cancer. Mol Cancer Ther. 12:1676–1687. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tichomirowa MA, Theodoropoulou M, Daly AF,
Yassouridis A, Hansen S, Lu J, Lange M, Goldbrunner RH, Stalla GK
and Renner U: Toll-like receptor-4 is expressed in meningiomas and
mediates the antiproliferative action of paclitaxel. Int J Cancer.
123:1956–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ustinova EE, Shurin GV, Gutkin DW and
Shurin MR: The role of TLR4 in the paclitaxel effects on neuronal
growth in vitro. PLoS One. 8:e568862013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ran S: The role of TLR4 in
chemotherapy-driven metastasis. Cancer Res. 75:2405–2410. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Volk-Draper L, Hall K, Griggs C, Rajput S,
Kohio P, DeNardo D and Ran S: Paclitaxel therapy promotes breast
cancer metastasis in a TLR4-dependent manner. Cancer Res.
74:5421–5434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Haricharan S and Brown P: TLR4 has a
TP53-dependent dual role in regulating breast cancer cell growth.
Proc Natl Acad Sci USA. 112:E3216–E3225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bonizzi G and Karin M: The two NF-kappaB
activation pathways and their role in innate and adaptive immunity.
Trends Immunol. 25:280–288. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Greten FR and Karin M: The IKK/NF-kappaB
activation pathway-a target for prevention and treatment of cancer.
Cancer Lett. 206:193–199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cogswell PC, Guttridge DC, Funkhouser WK
and Baldwin AS Jr: Selective activation of NF-kappa B subunits in
human breast cancer: Potential roles for NF-kappa B2/p52 and for
Bcl-3. Oncogene. 19:1123–1131. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Boutros C, Gary M, Baldwin K and
Somasundar P: Gallbladder cancer: Past, present and an uncertain
future. Surg Oncol. 21:e183–e191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Randi G, Franceschi S and La Vecchia C:
Gallbladder cancer worldwide: Geographical distribution and risk
factors. Int J Cancer. 118:1591–1602. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lazcano-Ponce EC, Miquel JF, Muñoz N,
Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista
G and Nervi F: Epidemiology and molecular pathology of gallbladder
cancer. CA Cancer J Clin. 51:349–364. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Everson GT, McKinley C and Kern F Jr:
Mechanisms of gallstone formation in women. Effects of exogenous
estrogen (Premarin) and dietary cholesterol on hepatic lipid
metabolism. J Clin Invest. 87:237–246. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Barreto SG, Haga H and Shukla PJ: Hormones
and gallbladder cancer in women. Indian J Gastroenterol.
28:126–130. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yuan Y, Liu L, Chen H, Wang Y, Xu Y, Mao
H, Li J, Mills GB, Shu Y, Li L and Liang H: Comprehensive
characterization of molecular differences in cancer between male
and female patients. Cancer Cell. 29:711–722. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Warnefors M, Mössinger K, Halbert J,
Studer T, VandeBerg JL, Lindgren I, Fallahshahroudi A, Jensen P and
Kaessmann H: Sex-biased microRNA expression in mammals and birds
reveals underlying regulatory mechanisms and a role in dosage
compensation. Genome Res. 27:1961–1973. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Guo L, Zhang Q, Ma X, Wang J and Liang T:
miRNA and mRNA expression analysis reveals potential sex-biased
miRNA expression. Sci Rep. 7:398122017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Duttagupta R, Jiang R, Gollub J, Getts RC
and Jones KW: Impact of cellular miRNAs on circulating miRNA
biomarker signatures. PLoS One. 6:e207692011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang K, Yuan Y, Cho JH, McClarty S, Baxter
D and Galas DJ: Comparing the MicroRNA spectrum between serum and
plasma. PLoS One. 7:e415612012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Langevin SM, Stone RA, Bunker CH, Grandis
JR, Sobol RW and Taioli E: MicroRNA-137 promoter methylation in
oral rinses from patients with squamous cell carcinoma of the head
and neck is associated with gender and body mass index.
Carcinogenesis. 31:864–870. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Srivastava K, Srivastava A and Mittal B:
Potential biomarkers in gallbladder cancer: Present status and
future directions. Biomarkers. 18:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
He CZ, Zhang KH, Li Q, Liu XH, Hong Y and
Lv NH: Combined use of AFP, CEA, CA125 and CAl9-9 improves the
sensitivity for the diagnosis of gastric cancer. BMC Gastroenterol.
13:872013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zur B, Holdenrieder S, Walgenbach-Brünagel
G, Albers E and Stoffel-Wagner B: Method comparison for
determination of the tumor markers AFP, CEA, PSA and free PSA
between Immulite 2000 XPI and Dimension Vista 1500. Clin Lab.
58:97–105. 2012.PubMed/NCBI
|
|
56
|
Zhang D, Yu M, Xu T and Xiong B:
Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of
colorectal liver metastasis in Chinese population.
Hepatogastroenterology. 60:1297–1301. 2013.PubMed/NCBI
|
|
57
|
Sicklick JK, Fanta PT, Shimabukuro K and
Kurzrock R: Genomics of gallbladder cancer: The case for
biomarker-driven clinical trial design. Cancer Metastasis Rev.
35:263–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Olivieri F, Antonicelli R, Capogrossi MC
and Procopio AD: Circulating microRNAs (miRs) for diagnosing acute
myocardial infarction: An exciting challenge. Int J Cardiol.
167:3028–3029. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhao S, Yan L and Zhao Z: Up-regulation of
miR-203 inhibits the growth of cervical cancer cells by inducing
cell cycle arrest and apoptosis. Eur J Gynaecol Oncol. 40:791–795.
2019.
|
|
60
|
Fichtlscherer S, De Rosa S, Fox H,
Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T,
Müller-Ardogan M, et al: Circulating microRNAs in patients with
coronary artery disease. Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Keller A and Meese E: Can circulating
miRNAs live up to the promise of being minimal invasive biomarkers
in clinical settings? Wiley Interdiscip Rev RNA. 7:148–156. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hussain SP and Harris CC: Inflammation and
cancer: An ancient link with novel potentials. Int J Cancer.
121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Mara MA, Good M and Weitkamp JH: Innate
and adaptive immunity in necrotizing enterocolitis. Semin Fetal
Neonatal Med. 23:394–399. 2018. View Article : Google Scholar : PubMed/NCBI
|
